Heike K. E. Nesbit

• Evaluation of an immunotherapeutical strategy for the clinical use of melanoma and breast cancer cells expressing the T cell co-stimulatory molecule B7-1 as a vaccine - evidence for the involvement of an immunosuppressive eicosanoid